Vertex Pharmaceuticals Inc / Ma

AQR CAPITAL MANAGEMENT LLC VRTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

143,651

Value ($000)

65,126

Weight

0.0%

2013 Q4 - 2025 Q4 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	65,126	0.0%	143,651	12/31/2025
2025 Q3	11/14/2025	63,322	0.0%	161,683	9/30/2025
2025 Q2	8/14/2025	62,235	0.1%	141,536	6/30/2025
2025 Q1	5/15/2025	69,630	0.1%	145,871	3/31/2025
2024 Q4	2/14/2025	98,978	0.1%	245,785	12/31/2024
2024 Q3	11/14/2024	223,119	0.3%	480,861	9/30/2024
2024 Q2	8/14/2024	251,287	0.4%	536,114	6/30/2024
2024 Q1	5/15/2024	278,684	0.5%	666,691	3/31/2024
2023 Q4	2/14/2024	262,350	0.5%	644,768	12/31/2023
2023 Q3	11/14/2023	223,770	0.5%	643,497	9/30/2023
2023 Q2	8/14/2023	215,520	0.5%	612,430	6/30/2023
2023 Q1	5/15/2023	180,050	0.4%	571,515	3/31/2023
2022 Q4	2/14/2023	168,534	0.4%	587,594	12/31/2022
2022 Q3	11/14/2022	143,187	0.3%	494,531	9/30/2022
2022 Q2	8/15/2022	143,878	0.3%	516,784	6/30/2022
2022 Q1	5/16/2022	128,931	0.2%	499,944	3/31/2022
2021 Q4	2/14/2022	131,427	0.2%	598,483	12/31/2021
2021 Q3	11/15/2021	115,965	0.2%	639,317	9/30/2021
2021 Q2	8/16/2021	139,294	0.2%	706,753	6/30/2021
2021 Q1	5/17/2021	195,226	0.3%	910,527	3/31/2021
2020 Q4	2/16/2021	129,106	0.2%	560,381	12/31/2020
2020 Q3	11/16/2020	174,977	0.3%	644,268	9/30/2020
2020 Q2	8/17/2020	175,695	0.3%	611,815	6/30/2020
2020 Q1	5/15/2020	138,087	0.2%	594,870	3/31/2020
2019 Q4	2/14/2020	89,624	0.1%	410,310	12/31/2019
2014 Q1	5/15/2014	32,176	0.1%	454,978	3/31/2014
2013 Q4	2/14/2014	38,701	0.1%	520,879	12/31/2013